West Pharmaceutical Services WST Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $844.9M+5.0% | $805M0.0% | $804.6M+5.0% | $766.5M+9.8% | $698M-6.8% | ||
| $548.5M+9.5% | $501.1M-1.8% | $510.3M+3.6% | $492.6M+5.7% | $466.1M-1.9% | ||
| $296.4M-2.5% | $303.9M+3.3% | $294.3M+7.4% | $273.9M+18.1% | $231.9M-15.2% | ||
| 35.1%-2.7pp | 37.8%+1.2pp | 36.6%+0.8pp | 35.7%+2.5pp | 33.2%-3.3pp | ||
| $15.8M-27.5% | $21.8M+27.5% | $17.1M-10.5% | $19.1M+17.2% | $16.3M-11.9% | ||
| $99.5M-7.0% | $107M+4.2% | $102.7M+7.1% | $95.9M+9.0% | $88M+3.2% | ||
| $177.1M+13.1% | $156.6M-6.6% | $167.6M+9.0% | $153.7M+43.6% | $107M-33.0% | ||
| 21%+1.5pp | 19.5%-1.4pp | 20.8%+0.8pp | 20.1%+4.7pp | 15.3%-6.0pp | ||
| $1.9M— | —— | $200K+100% | $100K-75.0% | $400K— | ||
| -$200K+50.0% | -$400K-100% | -$200K0.0% | -$200K0.0% | -$200K+98.2% | ||
| $180.1M+11.5% | $161.5M-6.1% | $171.9M+9.5% | $157M+42.1% | $110.5M-33.0% | ||
| $44.7M+34.2% | $33.3M-2.1% | $34M+12.6% | $30.2M+25.3% | $24.1M-34.5% | ||
| $138.8M+5.1% | $132.1M-5.6% | $140M+6.2% | $131.8M+46.8% | $89.8M-31.0% | ||
| 16.4%0.0pp | 16.4%-1.0pp | 17.4%+0.2pp | 17.2%+4.3pp | 12.9%-4.5pp | ||
| $1.92+5.5% | $1.82-5.2% | $1.92+5.5% | $1.82+48.0% | $1.23-30.9% | ||
| $222.3M+9.5% | $203M-3.6% | $210.6M+7.9% | $195.1M+32.7% | $147M-26.3% | ||
| 26.3%+1.1pp | 25.2%-1.0pp | 26.2%+0.7pp | 25.5%+4.4pp | 21.1%-5.6pp | ||
| $177.1M+13.1% | $156.6M-6.6% | $167.6M+9.0% | $153.7M+43.6% | $107M-33.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is West Pharmaceutical Services's revenue?
- West Pharmaceutical Services (WST) generated $3.2B in revenue over the trailing twelve months, up 11.2% year over year.
- Is West Pharmaceutical Services profitable?
- West Pharmaceutical Services reported $542.7M in net income over the trailing twelve months, a 16.8% net margin.
- What are West Pharmaceutical Services's profit margins?
- Gross margin is 36.3% and operating margin is 20.3%, with a 16.8% net margin.
- What is West Pharmaceutical Services's earnings per share?
- West Pharmaceutical Services's diluted EPS over the trailing twelve months is $7.48.
- Where does West Pharmaceutical Services's income statement data come from?
- Every line is extracted from West Pharmaceutical Services's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
